Ryan leads Quay Pharma clinical development service business for Live Biotherapeutic drug products. He has championed multiple projects working on both single strain and consortia products for both Phase I and Phase II clinical studies; involving both IMPD and IND submissions. Ryan has over 20 years’ experience spanning various technical, CMC outsourcing and programme management roles in the pharma and biotech sectors. He worked for Oxyrane as Head of Project Development and SSL innovation as their Innovation Manager.
Head of Live-Bio Therapeutics Programmes